Prenatal Exposure to Soy Isoflavones Altered the Immunological Parameters in Female Rats. 2016

Hala M Ebaid, and Rania Abdel Rahman Elgawish, and Heba M A Abdelrazek, and Ghada Gaffer, and Hend M Tag
Department of Zoology, Faculty of Science, Suez Canal University, Ismailia, Egypt.

Information on the effects of phytoestrogens on animals has increased recently; however, there were only few studies on prenatal exposure on cellular immune response. Pregnant rats were assigned to 3 groups (12 rats per group), the first was fed control diet, the second was fed low-dose (6.5 g/100 g of diet) soy isoflavones, while the third was fed high-dose (26 g/100 g of diet) soy isoflavones. The female offspring cell-mediated immune response was determined using phytohemagglutinin (PHA) injection, and intumesce index was calculated on postnatal day 50. After 24 hours of PHA injection, blood samples were collected for tumor necrosis factor α, interferon γ (IFN-γ), and interleukin (IL)-12 determination. Spleen, thymus, and PHA-injected footpads were fixed for histopathology. Intumesce index was significantly (P < 0.05) reduced in rats' offspring born from dams fed low- and high-dietary soy isoflavones than that in control groups. Thymic relative weights in offspring of rats fed high-dietary soy isoflavones showed a significant (P < 0.05) decrease compared to that in the control group. Female offspring where low and high-dietary soy isoflavones were fed to their dams showed a significant (P < 0.05) decrease in IFN-γ and IL-12 than that in control ones. Spleen of rats born from dams fed high dose of dietary soy isoflavones showed lymphocytic depletion in white pulp. Taking together, it is clear that dietary soy isoflavones at prenatal period had immunosuppressive effect on female offspring after PHA stimulation. This effect was mediated through reduced IFN-γ that interplayed in IL-12 production pathway thus reducing its level.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007529 Isoflavones 3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position. 3-Benzylchroman-4-One,3-Benzylidene-4-Chromanone,Homoisoflavone,Homoisoflavones,Isoflavone,Isoflavone Derivative,3-Benzylchroman-4-Ones,3-Benzylidene-4-Chromanones,Isoflavone Derivatives,3 Benzylchroman 4 One,3 Benzylchroman 4 Ones,3 Benzylidene 4 Chromanone,3 Benzylidene 4 Chromanones,Derivative, Isoflavone,Derivatives, Isoflavone
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D010835 Phytohemagglutinins Mucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes. They are used mainly in the study of immune mechanisms and in cell culture. Kidney Bean Lectin,Kidney Bean Lectins,Lectins, Kidney Bean,Phaseolus vulgaris Lectin,Phaseolus vulgaris Lectins,Phytohemagglutinin,Hemagglutinins, Plant,Lectin, Kidney Bean,Lectin, Phaseolus vulgaris,Lectins, Phaseolus vulgaris,Plant Hemagglutinins
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011297 Prenatal Exposure Delayed Effects The consequences of exposing the FETUS in utero to certain factors, such as NUTRITION PHYSIOLOGICAL PHENOMENA; PHYSIOLOGICAL STRESS; DRUGS; RADIATION; and other physical or chemical factors. These consequences are observed later in the offspring after BIRTH. Delayed Effects, Prenatal Exposure,Late Effects, Prenatal Exposure
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets

Related Publications

Hala M Ebaid, and Rania Abdel Rahman Elgawish, and Heba M A Abdelrazek, and Ghada Gaffer, and Hend M Tag
December 2004, The Journal of steroid biochemistry and molecular biology,
Hala M Ebaid, and Rania Abdel Rahman Elgawish, and Heba M A Abdelrazek, and Ghada Gaffer, and Hend M Tag
March 2008, Basic & clinical pharmacology & toxicology,
Hala M Ebaid, and Rania Abdel Rahman Elgawish, and Heba M A Abdelrazek, and Ghada Gaffer, and Hend M Tag
January 1999, Journal of medicinal food,
Hala M Ebaid, and Rania Abdel Rahman Elgawish, and Heba M A Abdelrazek, and Ghada Gaffer, and Hend M Tag
January 2019, Oxidative medicine and cellular longevity,
Hala M Ebaid, and Rania Abdel Rahman Elgawish, and Heba M A Abdelrazek, and Ghada Gaffer, and Hend M Tag
June 2004, Reproductive toxicology (Elmsford, N.Y.),
Hala M Ebaid, and Rania Abdel Rahman Elgawish, and Heba M A Abdelrazek, and Ghada Gaffer, and Hend M Tag
July 2023, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS),
Hala M Ebaid, and Rania Abdel Rahman Elgawish, and Heba M A Abdelrazek, and Ghada Gaffer, and Hend M Tag
July 2004, Reproductive toxicology (Elmsford, N.Y.),
Hala M Ebaid, and Rania Abdel Rahman Elgawish, and Heba M A Abdelrazek, and Ghada Gaffer, and Hend M Tag
March 2006, The Journal of endocrinology,
Hala M Ebaid, and Rania Abdel Rahman Elgawish, and Heba M A Abdelrazek, and Ghada Gaffer, and Hend M Tag
November 1993, Pharmacology & toxicology,
Hala M Ebaid, and Rania Abdel Rahman Elgawish, and Heba M A Abdelrazek, and Ghada Gaffer, and Hend M Tag
June 2022, Journal of periodontal research,
Copied contents to your clipboard!